Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Biotech Investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

Biotech Investing

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

life science investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

biotech investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

biotech investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

pharmaceutical investing

Successful Completion of Placement to Accelerate Clinical Programs

life science investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Sirona Biochem (SBM:CA)

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

Cardiol Therapeutics (CRDL:CA)

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Sirona Biochem (SBM:CA)

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update

life science investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis

InhaleRx Secures $38,500,000 Funding to Fully Fund Clinical Development Plans

life science investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×